BlueGenics Dissemination Event in Chengdu, China 2016

The BlueGenics coordinator, W.E.G. Müller, and project partner X.H. Wang performed a Dissemination event in Chengdu, China, where they presented the products, developed in the frame of the BlueGenics project, in particular the products developed by the partners UMC-Mainz, NRCGA-CAGS and the SME partner NanotecMARIN GmbH to an audience consisting of industrial researchers, researchers from academia and potential customers. The main event was in Chengdu. There was a special interest in the novel approaches, developed in the BlueGenics project, for wound healing, in particular delayed wound healing, and in the application of electrospinning procedures for the fabrication of bioactive wound dressings. Moreover, novel strategies and compounds/compound combinations for the therapy of osteoporotic bone disorders were discussed, in particular the application of quercetin/quercetin derivatives and their synergistic effects with inorganic polyphosphates, as well as the application of carbonic anhydrase activators (quinolinic acid, the first carbonic anhydrase activator acting on bone mineralization that has been discovered – one main result of BlueGenics project). The carbonic anhydrase is a new target for therapy of bone disorders with an impaired balance between bone anabolism and bone catabolism, like osteoporosis. In addition to the event in Chengdu, there was a second major dissemination events in Shanghai (see below), as well as several meetings with potential customers/users within the period 09.07.-24.07.2016.  





 Dissemination Event in Chengdu, China 2016. Presentation of the results of BlueGenics project by W.E.G. Müller (UMC-Mainz).